JP2018537469A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537469A5 JP2018537469A5 JP2018528313A JP2018528313A JP2018537469A5 JP 2018537469 A5 JP2018537469 A5 JP 2018537469A5 JP 2018528313 A JP2018528313 A JP 2018528313A JP 2018528313 A JP2018528313 A JP 2018528313A JP 2018537469 A5 JP2018537469 A5 JP 2018537469A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorph
- pulmonary fibrosis
- treating pulmonary
- administering
- fixed amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 12
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 10
- 241000282412 Homo Species 0.000 claims 5
- 210000004072 lung Anatomy 0.000 claims 5
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 2
- 210000003123 bronchiole Anatomy 0.000 claims 2
- 229940112141 dry powder inhaler Drugs 0.000 claims 2
- 238000000634 powder X-ray diffraction Methods 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 230000001351 cycling effect Effects 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021062805A JP2021105029A (ja) | 2015-12-18 | 2021-04-01 | 結晶多形とプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15201223.3 | 2015-12-18 | ||
| EP15201223 | 2015-12-18 | ||
| PCT/EP2016/081432 WO2017103109A1 (en) | 2015-12-18 | 2016-12-16 | Polymorphic forms and process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021062805A Division JP2021105029A (ja) | 2015-12-18 | 2021-04-01 | 結晶多形とプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018537469A JP2018537469A (ja) | 2018-12-20 |
| JP2018537469A5 true JP2018537469A5 (https=) | 2020-03-26 |
| JP6863984B2 JP6863984B2 (ja) | 2021-04-21 |
Family
ID=54979474
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018528313A Expired - Fee Related JP6863984B2 (ja) | 2015-12-18 | 2016-12-16 | 結晶多形とプロセス |
| JP2021062805A Pending JP2021105029A (ja) | 2015-12-18 | 2021-04-01 | 結晶多形とプロセス |
| JP2021142305A Active JP7254130B2 (ja) | 2015-12-18 | 2021-09-01 | 結晶多形および医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021062805A Pending JP2021105029A (ja) | 2015-12-18 | 2021-04-01 | 結晶多形とプロセス |
| JP2021142305A Active JP7254130B2 (ja) | 2015-12-18 | 2021-09-01 | 結晶多形および医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10369136B2 (https=) |
| EP (2) | EP3896075A1 (https=) |
| JP (3) | JP6863984B2 (https=) |
| CN (1) | CN108602847A (https=) |
| CA (1) | CA3004632A1 (https=) |
| ES (1) | ES2925864T3 (https=) |
| WO (1) | WO2017103109A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9243021B2 (en) * | 2012-10-31 | 2016-01-26 | Galecto Biotech Ab | Galactoside inhibitor of galectins |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
| DE69230613T2 (de) | 1991-07-02 | 2000-12-28 | Inhale Inc | Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform |
| EP0938907B1 (en) | 1996-01-03 | 2001-12-05 | Glaxo Group Limited | Inhalation device |
| US6962151B1 (en) | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
| US6482847B2 (en) * | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| DE10102846B4 (de) | 2001-01-23 | 2012-04-12 | Pari Pharma Gmbh | Aerosolgenerator |
| ATE269735T1 (de) | 2001-10-18 | 2004-07-15 | Pari Gmbh | Inhalationstherapievorrichtung |
| DE60235883D1 (de) | 2002-08-02 | 2010-05-20 | Pari Pharma Gmbh | Vorrichtung zur Erzeugung von Flüssigkeitströpfchen |
| DE10250625A1 (de) | 2002-10-30 | 2004-05-19 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
| DE10257381B4 (de) | 2002-12-09 | 2006-09-14 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
| PT104350A (pt) * | 2009-01-23 | 2010-07-23 | Hovione Farmaci Ncia S A | Processo de isolamento de tigeciclina |
| DE102009026636B4 (de) | 2009-06-02 | 2011-04-14 | Pari Pharma Gmbh | Verfahren zum Verschweißen einer Membran mit einem Träger bei der Herstellung eines Membranverneblers |
| US9243021B2 (en) | 2012-10-31 | 2016-01-26 | Galecto Biotech Ab | Galactoside inhibitor of galectins |
| CN104755088A (zh) * | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| EP2919802A4 (en) * | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| WO2015155207A1 (en) * | 2014-04-08 | 2015-10-15 | Galecto Biotech Ab | Galactoside inhibitors for the treatment of alpha-synucleinopthies |
-
2016
- 2016-12-16 EP EP21175042.7A patent/EP3896075A1/en not_active Withdrawn
- 2016-12-16 EP EP16809870.5A patent/EP3390423B1/en active Active
- 2016-12-16 CN CN201680071057.8A patent/CN108602847A/zh active Pending
- 2016-12-16 ES ES16809870T patent/ES2925864T3/es active Active
- 2016-12-16 US US16/062,206 patent/US10369136B2/en active Active
- 2016-12-16 WO PCT/EP2016/081432 patent/WO2017103109A1/en not_active Ceased
- 2016-12-16 CA CA3004632A patent/CA3004632A1/en active Pending
- 2016-12-16 JP JP2018528313A patent/JP6863984B2/ja not_active Expired - Fee Related
-
2018
- 2018-11-28 US US16/202,487 patent/US10307403B2/en active Active
-
2019
- 2019-05-13 US US16/410,110 patent/US10799482B2/en active Active
-
2021
- 2021-04-01 JP JP2021062805A patent/JP2021105029A/ja active Pending
- 2021-09-01 JP JP2021142305A patent/JP7254130B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7069253B2 (ja) | 統合失調症を治療するための２－（（１－（２（４－フルオロフェニル）－２－オキソエチル）ピペリジン－４－イル）メチル）イソインドリン－１－オン | |
| JP6918819B2 (ja) | オルトミクソウイルス感染の処置に有用な三環式化合物 | |
| JP2016534063A5 (https=) | ||
| JP2017528503A5 (https=) | ||
| JP2012529486A5 (https=) | ||
| JP2011528658A5 (https=) | ||
| JP2017528506A5 (https=) | ||
| TWI450893B (zh) | Inhibition of prostaglandin D synthase in the piper Compounds | |
| JP2017528507A5 (https=) | ||
| JP2009084270A5 (https=) | ||
| JP2014515013A5 (https=) | ||
| JP2018515495A5 (https=) | ||
| BR112012024785A2 (pt) | antagonista do receptor de cgrp | |
| JP2008533007A5 (https=) | ||
| JP2017537954A5 (https=) | ||
| JP2016540749A5 (https=) | ||
| JP2016510326A5 (https=) | ||
| JP2019501879A5 (https=) | ||
| JP2019505529A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| EA022018B1 (ru) | Кристаллические оксалатные соли диамидного соединения | |
| JP2019529460A5 (https=) | ||
| JP5833143B2 (ja) | フェニル−イソオキサゾール誘導体およびその製造方法 | |
| JP2025508071A5 (https=) | ||
| JP2022527618A5 (https=) |